These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6364898)

  • 1. [Infectious agents : current concepts and perspectives].
    Pijck J; Vuye A
    Ann Biol Clin (Paris); 1983; 41(6):383-92. PubMed ID: 6364898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial immunotherapies for infectious diseases.
    Hengel H; Masihi KN
    Int Immunopharmacol; 2003 Aug; 3(8):1159-67. PubMed ID: 12860171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunodeficiency development in non-specific infectious inflammation].
    Kazimirskiĭ AN; Poriadin GV; Salmasi ZhM
    Patol Fiziol Eksp Ter; 2003; (3):23-6. PubMed ID: 14518105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Infectious diseases-Part II: New agents, resistances, and treatment strategies].
    Salzberger B; Franzen C; Glück T
    Med Klin (Munich); 2004 May; 99(5):251-60. PubMed ID: 15146288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infectious diseases--new horizons].
    Spirer Z; Barzilai A
    Harefuah; 2012 Aug; 151(8):483-7, 496. PubMed ID: 23350296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pediatric infectious diseases--an ongoing battle].
    Spirer Z; Barzilai A
    Harefuah; 2012 Aug; 151(8):447-9, 499. PubMed ID: 23350286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for pathogen-specific therapy.
    Casadevall A
    Expert Opin Pharmacother; 2009 Aug; 10(11):1699-703. PubMed ID: 19558338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging concepts of biofilms in infectious diseases.
    Hung CS; Henderson JP
    Mo Med; 2009; 106(4):292-6. PubMed ID: 19753923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing antimicrobial resistance: the key role of the infectious diseases physician.
    McGowan JE
    Clin Infect Dis; 2004 Apr; 38(7):939-42. PubMed ID: 15034824
    [No Abstract]   [Full Text] [Related]  

  • 11. The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s.
    Armstrong D; Neu H; Peterson LR; Tomasz A
    Microb Drug Resist; 1995; 1(1):1-4. PubMed ID: 9156378
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biotechnologic drugs and chemotherapy for infectious diseases].
    Honorato J
    Rev Esp Quimioter; 2007 Sep; 20(3):310-6. PubMed ID: 18080027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings.
    Diazgranados CA; Cardo DM; McGowan JE
    Int J Antimicrob Agents; 2008 Jul; 32(1):1-9. PubMed ID: 18550343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back from the dead. Emerging and re-emerging infectious diseases.
    Cornell S
    Adv Nurse Pract; 1998 May; 6(5):67-8. PubMed ID: 9633297
    [No Abstract]   [Full Text] [Related]  

  • 16. Could repurposing existing drugs be an efficient protective method against microbial biologic threats?
    Chopra S
    Future Microbiol; 2013 Aug; 8(8):951-2. PubMed ID: 23902140
    [No Abstract]   [Full Text] [Related]  

  • 17. The current state of infectious disease: a clinical perspective on antimicrobial resistance.
    Shay LE; Freifeld AG
    Lippincotts Prim Care Pract; 1999; 3(1):1-15; quiz 16-8. PubMed ID: 10214199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of Existing Statin Drugs for Treatment of Microbial Infections: How Much Promising?
    Rana R; Sharma R; Kumar A
    Infect Disord Drug Targets; 2019; 19(3):224-237. PubMed ID: 30081793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The infrequency and exceptionality of infectious pathology].
    Soriano F
    Enferm Infecc Microbiol Clin; 1993 Nov; 11(9):465-7. PubMed ID: 8305551
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial resistance: A multifaceted problem with multipronged solutions.
    Gil-Gil T; Laborda P; Sanz-García F; Hernando-Amado S; Blanco P; Martínez JL
    Microbiologyopen; 2019 Nov; 8(11):e945. PubMed ID: 31724836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.